Webinar on Patent Exclusivity for Small Molecules

Strafford will be offering a webinar entitled "Patent Exclusivity Health Checks for Small Molecules: Are Your U.S. Patents Ready to Maximize ROI? — Phase II Efficacy Trials, Phase III Clinical Trials, NDA Submission, Approval and Marketing" on March 8, 2018 from 1:00 to 2:30 pm (EST). Thomas L. Irving, Shana K. Cyr, Mark J. Feldstein, and John D. Livingstone of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to patent counsel on the essentials of patent exclusivity that are in critical need of independent checking, and discuss crucial health checks on U.S. patent exclusivity for small molecules in Phase…Original Article